Aimee J. Lenar's most recent trade in Bausch Health Companies Inc was a trade of 30,847 Common Shares, No Par Value done . Disclosure was reported to the exchange on July 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc | Aimee J. Lenar | EVP, US Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2025 | 30,847 | 260,774 (0%) | 0% | 0 | Common Shares, No Par Value | |
| Bausch Health Companies Inc | Aimee J. Lenar | EVP, US Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.42 per share. | 15 Jul 2025 | 22,736 | 229,927 (0%) | 0% | 6.4 | 145,965 | Common Shares, No Par Value |
| Bausch Health Companies Inc | Aimee J. Lenar | EVP, US Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 108,311 | 252,663 (0%) | 0% | 0 | Common Shares, No Par Value | |
| Bausch Health Companies Inc | Aimee J. Lenar | EVP, US Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 144,352 | 144,352 (0%) | 0% | 0 | Common Shares, No Par Value |